D Alem, X Yang, F Beato, B Sarcar, AF Tassielli,
R Dai… - bioRxiv, 2022 - biorxiv.org
Background It has been challenging to develop agents directly targeting KRAS driver
mutations in colorectal cancer (CRC). Recent efforts have focused on developing inhibitors …